HAS Acquires Cerbios-Pharma to Enhance Pharmaceutical Capabilities
Deal News (Announced) | Mar 31, 2025 | Finance Community IT - 1 Corporate M&A
Healthcare Advanced Synthesis (HAS), a Swiss pharmaceutical company specializing in active pharmaceutical ingredients (API), has acquired Cerbios-Pharma. Cerbios is a globally recognized API producer, including the expanding field of antibody-drug conjugates (ADC). This strategic move, supported by global investment firm 65 Equity Partners, positions the merged entity as a leader in the CDMO (Contract Development and Manufacturing Organization) sector, leveraging both companies' strengths in chemical and biological production. 65 Equity Partners takes a 40% stake, while the Braglia family retains majority ownership. The union aims to capitalize on growing demands in complex therapies and technological innovation within various therapeutic domains. Financial and legal advisors including Rothschild, EY, and others facilitated the transaction.
Sectors
- Pharmaceuticals
- Private Equity
Geography
- Switzerland – Both HAS and Cerbios-Pharma are headquartered in Switzerland, and the transaction is taking place there.
Industry
- Pharmaceuticals – The article discusses HAS's acquisition of Cerbios-Pharma, both of which operate in the pharmaceutical sector, particularly in API and ADC production.
- Private Equity – 65 Equity Partners' investment in the HAS-Cerbios deal highlights the role of private equity in facilitating M&A transactions.
Financials
- 40% – The ownership stake acquired by 65 Equity Partners in HAS as part of the acquisition of Cerbios-Pharma.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| HAS Healthcare Advanced Synthesis | Acquirer | Company | A global pharmaceutical company specializing in the development and production of APIs and HPAPIs. |
| Cerbios-Pharma | Target | Company | A globally recognized producer of chemical and biological APIs, notably active in ADCs. |
| 65 Equity Partners | Investor | Company | A global investment firm supporting the acquisition with strategic and financial backing. |
| Rothschild & Co | Financial Advisor | Company | Advised HAS on the acquisition, facilitating the financial components of the deal. |
| Br & Karrer | Legal Advisor | Company | Provided legal services for HAS in the transaction. |
| EY | Due Diligence Advisor | Company | Conducted financial and tax due diligence for both HAS and 65 Equity Partners. |
| UBS AG | Financial Advisor | Company | Provided financial advice to 65 Equity Partners during the acquisition process. |
| Ropes & Gray | Legal Advisor | Company | Provided legal services to 65 Equity Partners for the acquisition. |
| Walder Wyss | Legal Advisor | Company | Assisted 65 Equity Partners with legal advice in the acquisition. |
| Braglia Family | Majority Shareholder | People | Retains majority ownership of the combined HAS-Cerbios entity post-acquisition. |